Year of publication
Type of media
Type of material
Licence
Language
1–20 of 71 hits
Sort by:
Sort by:
-
Anticancer composition comprising recombinant adenovirus expressing degradation factor for extracellular matrix
Free accessEuropean Patent Office | 2023| -
ANTICANCER COMPOSITION COMPRISING TUMOR-SPECIFIC ONCOLYTIC ADENOVIRUS AND IMMUNE CHECKPOINT INHIBITOR
Free accessEuropean Patent Office | 2022| -
Anticancer composition comprising tumor-specific oncolytic adenovirus and immune checkpoint inhibitor
Free accessEuropean Patent Office | 2022| -
ANTICANCER COMPOSITION COMPRISING TUMOR-SPECIFIC KILLER ADENOVIRUS AND IMMUNE CHECKPOINT INHIBITOR
Free accessEuropean Patent Office | 2023| -
ANTICANCER COMPOSITION COMPRISING RECOMBINANT ADENOVIRUS EXPRESSING DEGRADATION FACTOR FOR EXTRACELLULAR MATRIX
Free accessEuropean Patent Office | 2023| -
ANTICANCER COMPOSITION CONTAINING A TUMOR-SPECIFIC ONCOLYTIC ADENOVIRUS AND AN IMMUNE RESPONSE CONTROL POINT INHIBITOR
Free accessEuropean Patent Office | 2021| -
Anticancer Composition Comprising Tumor-Specific Oncolytic Adenovirus And Immune Checkpoint Inhibitor
Free accessEuropean Patent Office | 2022| -
ANTITUMOR IMMUNITY ENHANCING COMPOSITION CONTAINING ADENOVIRUS SIMULTANEOUSLY EXPRESSING IL-12 AND SHVEGF
Free accessEuropean Patent Office | 2022| -
Anti-tumor composition comprising oncologic adenovirus and immune checkpoint inhibitor
Free accessEuropean Patent Office | 2020| -
ANTICANCER COMPOSITIONS COMPRISING TUMOR SPECIFIC ONCOLYTIC ADENOVIRUS AND IMMUNE CHECKPOINT INHIBITORS
Free accessEuropean Patent Office | 2021| -
ANTICANCER COMPOSITION COMPRISING TUMOR-SPECIFIC ONCOLYTIC ADENOVIRUS AND IMMUNE CHECKPOINT INHIBITOR
Free accessEuropean Patent Office | 2021| -
Anticancer composition comprising tumor-specific oncolytic adenovirus and immune checkpoint inhibitor
Free accessEuropean Patent Office | 2022| -
Anticancer Composition Comprising Recombinant Adenovirus Expressing Degradation Factor For Extracellular Matrix
Free accessEuropean Patent Office | 2021| -
ANTICANCER COMPOSITION CONTAINING A RECOMBINANT ADENOVIRUS EXPRESSING A DESTRUCTIVE FACTOR FOR AN EXTRACELLULAR MATRIX
Free accessEuropean Patent Office | 2021| -
ANTITUMOR IMMUNITY ENHANCING COMPOSITION CONTAINING ADENOVIRUS SIMULTANEOUSLY EXPRESSING IL-12 AND SHVEGF
Free accessEuropean Patent Office | 2021| -
Composición que potencia de la inmunidad antitumoral que contiene adenovirus que expresa simultáneamente IL-12 y SHVEGF
Free accessEuropean Patent Office | 2021| -
ANTICANCER COMPOSITION COMPRISING RECOMBINANT ADENOVIRUS EXPRESSING DEGRADATION FACTOR FOR EXTRACELLULAR MATRIX
Free accessEuropean Patent Office | 2020| -
12 Compositions for enhancing antitumor immunity comprising an oncolytic adenovirus co-expressing interleukin-12 and shVEGF
Free accessEuropean Patent Office | 2019| -
ANTICANCER COMPOSITION COMPRISING TUMOR-SPECIFIC ONCOLYTIC ADENOVIRUS AND IMMUNE CHECKPOINT INHIBITOR
Free accessEuropean Patent Office | 2019|
Send my search to (beta)
Send your search query (search terms without filters) to other databases, portals and catalogues to find more interesting hits.
Dimensions:
full data search
or
title and abstract search
Dimensions is a database for abstracts and citations that links information on research funding with the resulting publications, studies and patents.
TIB AV portal
In the TIB AV-Portal, audiovisual media from science and teaching can be foundand own scientific videos can be published.
Specialised Information Service for Mobility and Transport Research (FID move)
Open Research Knowledge Graph (ORKG)
The FID move can be used to search for subject-specific literature, research data and other information from mobility and transport research.
The Open Research Knowledge Graph provides structured descriptions of research content and makes it comparable.
Common Union Catalogue (GVK)
Freely accessible part of the collaborative K10plus catalogue with materials relevant for interlibrary loan and direct delivery services.